OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
Sonia Jangra, Gabriel Laghlali, Angela Choi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Sonia Jangra, Gabriel Laghlali, Angela Choi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Showing 13 citing articles:
A Polymer-Based Antigen Carrier Activates Two Innate Immune Pathways for Adjuvant-Free Subunit Vaccines
Hang Chen, Luyao Wang, Xiao‐Fan Zhao, et al.
ACS Nano (2024) Vol. 18, Iss. 12, pp. 9160-9175
Closed Access | Times Cited: 7
Hang Chen, Luyao Wang, Xiao‐Fan Zhao, et al.
ACS Nano (2024) Vol. 18, Iss. 12, pp. 9160-9175
Closed Access | Times Cited: 7
TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 15
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 15
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models
Prajakta Warang, Gagandeep Singh, Mahan Moshir, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Prajakta Warang, Gagandeep Singh, Mahan Moshir, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2
Jingbo Huang, Weiqi Wang, Hailun Li, et al.
Antiviral Research (2024) Vol. 227, pp. 105905-105905
Closed Access | Times Cited: 3
Jingbo Huang, Weiqi Wang, Hailun Li, et al.
Antiviral Research (2024) Vol. 227, pp. 105905-105905
Closed Access | Times Cited: 3
Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5909-5909
Open Access | Times Cited: 2
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5909-5909
Open Access | Times Cited: 2
Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia
Lauren A. Chang, Angela Choi, Raveen Rathnasinghe, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Lauren A. Chang, Angela Choi, Raveen Rathnasinghe, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in QIV vaccinated mice.
Sonia Jangra, Alexander Lamoot, Gagandeep Singh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Sonia Jangra, Alexander Lamoot, Gagandeep Singh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Discovery of an ellipticine derivative as TLR3 inhibitor against influenza A virus and SARS-CoV-2
Yue Pan, Qiuyue Fu, Yinyan Li, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 101, pp. 129672-129672
Closed Access | Times Cited: 1
Yue Pan, Qiuyue Fu, Yinyan Li, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 101, pp. 129672-129672
Closed Access | Times Cited: 1
Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant.
Jia Ji, Tao-Ming Tang, Miaojin Zhu, et al.
Antiviral Research (2024) Vol. 229, pp. 105954-105954
Closed Access | Times Cited: 1
Jia Ji, Tao-Ming Tang, Miaojin Zhu, et al.
Antiviral Research (2024) Vol. 229, pp. 105954-105954
Closed Access | Times Cited: 1
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice
Sonia Jangra, Alexander Lamoot, Gagandeep Singh, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Sonia Jangra, Alexander Lamoot, Gagandeep Singh, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Efficient Dendritic Cell Activation by a Layered Double Hydroxide‐loaded Dual Adjuvant Cocktail
Yi Jiang, Chenglun Tang, Yilun Wu, et al.
ChemNanoMat (2024)
Open Access
Yi Jiang, Chenglun Tang, Yilun Wu, et al.
ChemNanoMat (2024)
Open Access
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
Irene González‐Domínguez, Eduard Puente‐Massaguer, Adam Abdeljawad, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Irene González‐Domínguez, Eduard Puente‐Massaguer, Adam Abdeljawad, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
PEG-Polymeric Nanocarriers Alleviate the Immunosuppressive Effects of Free 4-Thiazolidinone-Based Chemotherapeutics on T Lymphocyte Function and Cytokine Production
Jana Tulinská, Lesya Коbylinska, Miroslava Lehotská Mikušová, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 14021-14041
Open Access
Jana Tulinská, Lesya Коbylinska, Miroslava Lehotská Mikušová, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 14021-14041
Open Access
